Zantac’s manufacturers were on a roll. Their defense had exacted a spate of favorable decisions and jury verdicts. Yet, on October 9, Glaxo Smith Kline (GSK) suddenly settled 93% of the remaining ...

GSK has opted to settle a key lawsuit in its defence against claims that its Zantac drug caused cancer, rather than proceed with a jury trial. The company said this morning it had reached a ...

Boehringer Ingelheim, a former manufacturer that has not settled, is in court in California this week defending itself in a jury trial brought by a man who claims that over-the-counter Zantac ...

A woman’s screams pierced the silence inside the second floor Sampson County courtroom Tuesday afternoon, then they came ...

GSK’s move doesn’t end litigation around Zantac as other drugmakers are still facing trials, including Boehringer Ingelheim GmbH, which is facing a jury trial in Oakland.

GSK’s move doesn’t end litigation around Zantac as other drugmakers are still facing trials, including Boehringer Ingelheim GmbH, which is facing a jury trial in Oakland.

Angela Valadez, 89, used over-the-counter Zantac religiously for 18 years before being diagnosed with colorectal cancer, she said in her lawsuit. She’s now seeking at least $640-million in ...

A trial involving the 2022 shooting of a Sampson County deputy ended Friday with a hung jury unable to reach a verdict on a ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...

Mark Shin, 31, faced charges including cyber theft after minting 14 million tokens of cryptocurrency. Alex Rose discusses why the trial ended in a hung jury.